See more : Bluescape Opportunities Acquisition Corp. (BOAC-UN) Income Statement Analysis – Financial Results
Complete financial analysis of Neptune Wellness Solutions Inc. (NEPT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neptune Wellness Solutions Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Tokyo Automatic Machinery Works, Ltd. (6360.T) Income Statement Analysis – Financial Results
- JALUX Inc. (2729.T) Income Statement Analysis – Financial Results
- Atlas Arteria Limited (MAQAF) Income Statement Analysis – Financial Results
- Alpha Partners Technology Merger Corp. (APTMU) Income Statement Analysis – Financial Results
- 3M India Limited (3MINDIA.NS) Income Statement Analysis – Financial Results
Neptune Wellness Solutions Inc. (NEPT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neptunewellness.com
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 52.62M | 61.01M | 44.49M | 29.58M | 24.44M | 27.65M | 43.22M | 22.63M | 15.07M | 19.50M | 25.95M | 19.25M | 17.06M | 12.05M | 10.32M | 7.60M | 6.28M | 4.01M | 1.66M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 74.45M | 71.58M | 80.07M | 31.42M | 16.83M | 21.32M | 31.40M | 18.06M | 23.09M | 16.97M | 15.63M | 9.12M | 14.21M | 10.61M | 8.91M | 5.88M | 5.90M | 3.62M | 2.71M | 2.71M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -21.84M | -10.58M | -35.58M | -1.84M | 7.61M | 6.32M | 11.82M | 4.57M | -8.02M | 2.52M | 10.31M | 10.13M | 2.85M | 1.43M | 1.41M | 1.72M | 382.33K | 398.16K | -1.05M | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | -41.51% | -17.34% | -79.96% | -6.22% | 31.15% | 22.88% | 27.34% | 20.18% | -53.20% | 12.93% | 39.75% | 52.64% | 16.68% | 11.91% | 13.69% | 22.57% | 6.09% | 9.92% | -62.95% | -62.95% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 484.22K | 1.10M | 2.43M | 2.94M | 7.29M | 15.30M | 6.69M | 7.14M | 9.98M | 8.53M | 8.18M | 3.93M | 2.59M | 2.61M | 487.30K | 362.29K | 338.33K | 155.71K | 175.82K | 597.55K | 647.78K | 419.88K | 103.26K | 103.26K |
General & Administrative | 0.00 | 0.00 | 89.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.60M | 26.52M | 15.32M | 9.86M | 736.02K | 461.05K | 2.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 357.74K | 18.06K | 18.06K |
Selling & Marketing | 0.00 | 0.00 | -19.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.45M | 2.24M | 2.41M | 2.10M | 0.00 | 0.00 | 2.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.83K | 11.83K | 0.00 |
SG&A | 46.42M | 75.81M | 81.62M | 62.16M | 15.29M | 15.30M | 15.75M | 13.75M | 23.63M | 32.00M | 18.15M | 11.96M | 736.02K | 461.05K | 4.52M | 2.65M | 2.65M | 0.00 | 0.00 | 1.17M | 1.01M | 369.57K | 18.06K | 18.06K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 730.97K | 1.05M | 599.87K | 532.19K | 944.48K | 777.08K | 707.85K | 33.57K | 23.79K | 5.77K | 0.00 |
Operating Expenses | 46.91M | -92.30M | -122.78M | -53.99M | -30.42M | 2.48M | -6.34M | -15.99M | -20.84M | -24.77M | -29.26M | 15.90M | 4.57M | 3.80M | 5.61M | 3.54M | 1.28M | 932.80K | 883.67K | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
Cost & Expenses | 102.00M | -20.71M | -42.71M | -22.57M | -13.59M | 23.81M | 25.06M | 2.08M | 2.25M | -7.80M | -13.63M | 25.01M | 18.79M | 14.42M | 14.51M | 9.42M | 7.18M | 4.55M | 3.59M | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
Interest Income | 1.45K | 7.12K | 38.33K | 106.63K | 184.73K | 176.14K | 0.00 | 78.47K | 122.76K | 12.82K | 145.69K | 124.58K | 22.88K | 43.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 30.08K | 0.00 |
Interest Expense | 2.20M | 1.54M | 916.09K | 411.58K | 340.87K | 1.04M | -2.49M | 1.07M | 696.38K | 0.00 | 156.56K | 381.81K | 397.89K | 645.42K | 1.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 0.00 |
Depreciation & Amortization | 3.69M | 7.60M | 23.96M | 7.93M | 3.05M | 3.54M | 3.52M | 2.58M | 1.72M | 352.94K | 613.20K | 768.41K | 943.32K | 730.97K | 599.87K | 532.19K | 966.03K | 797.10K | 724.96K | 39.90K | 23.79K | -5.77K | -5.77K | 0.00 |
EBITDA | -63.05M | -79.89M | -95.65M | -58.94M | -11.84M | -18.99M | -4.88M | -13.19M | -39.51M | -37.27M | -14.86M | -4.87M | -3.41M | -1.59M | -3.34M | -1.11M | -950.60K | 324.37K | -1.20M | -1.76M | -1.66M | -789.45K | -121.32K | -121.32K |
EBITDA Ratio | -119.84% | -130.95% | -214.99% | -199.28% | -48.43% | -68.69% | -11.28% | -58.27% | -262.19% | -191.16% | -57.26% | -25.30% | -20.01% | -13.22% | -32.39% | -14.59% | -15.14% | 8.08% | -72.51% | -106.11% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -66.74M | -87.49M | -119.61M | -66.87M | -14.88M | -22.53M | -8.40M | -15.77M | -41.23M | -37.62M | -15.47M | -5.76M | -1.87M | -3.01M | -4.19M | -1.83M | -900.48K | -534.64K | -1.93M | -1.80M | -1.68M | -795.22K | -121.32K | -121.32K |
Operating Income Ratio | -126.85% | -143.41% | -268.84% | -226.08% | -60.89% | -81.50% | -19.44% | -69.67% | -273.60% | -192.97% | -59.63% | -29.94% | -10.96% | -25.01% | -40.61% | -24.02% | -14.34% | -13.32% | -116.18% | -108.51% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -53.28M | -17.02M | -40.94M | 10.61M | -8.14M | 30.23M | 11.38M | 3.01M | 11.65M | 15.38M | -3.49M | 138.13K | 2.63M | 1.55M | 2.30M | -184.53K | 1.94M | -61.91K | -1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | -120.02M | -105.55M | -160.55M | -56.26M | -23.02M | 7.70M | 2.98M | -12.76M | -29.58M | -22.24M | -18.96M | -5.63M | 760.09K | -1.46M | -1.89M | -2.01M | 115.69K | -596.54K | -1.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -228.11% | -173.01% | -360.85% | -190.22% | -94.19% | 27.85% | 6.91% | -56.37% | -196.27% | -114.06% | -73.08% | -29.22% | 4.46% | -12.12% | -18.31% | -26.45% | 1.84% | -14.86% | -119.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -38.31M | -11.82M | 4.37M | 4.60M | 170.01K | 1.64M | 2.17M | 1.93M | 245.09K | 0.00 | 1.00M | -1.01M | -2.25M | 645.42K | 620.39K | 678.09K | -95.65K | 873.96K | 603.31K | 628.25K | -12.48K | -18.54K | 5.77K | 121.32K |
Net Income | -81.71M | -93.73M | -154.80M | -60.86M | -23.19M | 17.53M | 6.38M | -7.47M | -27.96M | -16.64M | -16.77M | -4.62M | 527.52K | -1.46M | -4.81M | -2.50M | -804.82K | -1.41M | -2.59M | -2.43M | -1.67M | -765.13K | -121.32K | -121.32K |
Net Income Ratio | -155.30% | -153.64% | -347.93% | -205.77% | -94.88% | 63.41% | 14.77% | -33.01% | -185.54% | -85.35% | -64.64% | -24.00% | 3.09% | -12.12% | -46.62% | -32.95% | -12.82% | -35.08% | -156.24% | -146.35% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -138.09 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
EPS Diluted | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -140.00 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
Weighted Avg Shares Out | 295.31K | 120.61K | 86.54K | 64.27K | 56.81K | 56.14K | 55.68K | 53.36K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
Weighted Avg Shares Out (Dil) | 295.31K | 120.61K | 86.63K | 64.27K | 56.81K | 56.69K | 55.82K | 54.10K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
Neptune Wellness Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial Intelligence Company, Datasys, for Total Potential Consideration of $112 Million
Neptune Wellness Solutions Inc. (NEPT) Q2 2024 Earnings Call Transcript
Neptune Reports Fiscal Second Quarter 2024 Financial Results
Neptune Wellness Announces Completion of Sprout Organic's Debt Equitization
Neptune Wellness Announces Repayment of Senior Secured Notes
Neptune Wellness Solutions Inc. Closes US$4.5 Million Public Offering
These Canadian Marijuana Stocks Are Top Companies To Watch
Why Is Neptune Wellness Solutions (NEPT) Stock Down 44% Today?
Neptune Wellness Solutions Inc. Announces Pricing of US$4.5 Million Public Offering
Neptune Wellness Announces Intention to Spinout Sprout Organics Pursuant to the Morgan Stanley Agreed To Transaction
Source: https://incomestatements.info
Category: Stock Reports